Citation Impact
Citing Papers
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
2011 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response.
1999
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Myeloproliferative disorders: complications, survival and causes of death
2000
RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)
1999
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Chronic myelogenous leukemia in nonlymphoid blastic phase
1999
Colony-stimulating factor-producing tumours: Production of granulocyte colony-stimulating factor and interleukin-6 is secondary to interleukin-1 production
1994 StandoutNobel
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Langerhans'-Cell Histiocytosis (Histiocytosis X) -- A Clonal Proliferative Disease
1994 Standout
Stability of K-ras mutations throughout the natural history of human colorectal cancer
1992
Pathogenesis of polycythaemia vera
1997
Variable X‐chromosome DNA methylation patterns detected with probe M27β in a series of lymphoid and myeloid malignancies
1991
RAS gene mutations in childhood acute myeloid leukemia: A pediatric oncology group study
1990
Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler technology
2000
Genetic instabilities in human cancers
1998 StandoutNature
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
1997 Standout
Stimulus‐specific defect in platelet aggregation in polycythemia vera
1994
C1q Binding to Platelets Induced by Monoclonal Antibodies and Immune Complexes—A Flow Cytometric Analysis
1993 StandoutNobel
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
1997
Chronic myelogenous leukemia: A review
1996
All ras proteins are polyisoprenylated but only some are palmitoylated
1989 Standout
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
2002 StandoutNobel
Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders
2004
The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors
1992 Standout
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
1997 Standout
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
2013 Standout
Increased intraplatelet levels of platelet‐derived growth factor and transforming growth factor‐β in patients with myelofibrosis with myeloid metaplasia
1991
Primary vs. secondary neoplasia-associated chromosomal abnormalities—balanced rearrangements vs. genomic imbalances?
1996
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Nonrandom structural and numerical chromosome changes in non‐small‐cell lung cancer
1991
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
X‐chromosome inactivation patterns using HPRT and PGK polymorphisms in haematologically normal and post‐chemotherapy females
1991
Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia
2005
The ras gene family and human carcinogenesis
1988
Stem cell origins of leukaemia and curability
1993
Impaired Platelet Binding of Fibrinogen Due to a Lower Number of GPIIB/IIIA Receptors in Polycythemia Vera
1998 StandoutNobel
The Effect of Formalin Fixation on Restriction Endonuclease
1993 StandoutNobel
Platelet Density Distribution in Essential Thrombocythemia
2010 StandoutNobel
The chronic myeloproliferative disorders: Clonality and clinical heterogeneity
2004
Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpression
2003
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
1997 Standout
Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs
1999
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
1988 Standout
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
The Effect of Formalin Fixation on DNA and the Extraction of High-molecular-weight DNA from Fixed and Embedded Tissues
1993 StandoutNobel
Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia
1990
Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells
1998
VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site
1990 Standout
Chromosomal location and structure of amplicons in two human cell lines with coamplification of c-myc and Ki-ras oncogenes
1993 StandoutNobel
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
2000 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Studies of Fibrinogen Binding to Platelets by Flow Cytometry: An Improved Method for Studies of Platelet Activation
1992 StandoutNobel
Rapid chemosensitivity testing of human lung tumor cells using the MTT assay
1986
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]
1995 Standout
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
T-cell immunity to the joining region of p210BCR-ABL protein.
1992
Acceleration of chronic myeloid leukemia correlates with calcitonin gene hypermethylation
1991
Mutations and Expression of the ras Family Genes in Leukemias
1996
The BCR-ABL Oncogene Transforms Rat-1 Cells and Cooperates with v-myc
1989
Induction of Chronic Myelogenous Leukemia in Mice by the P210 bcr/abl Gene of the Philadelphia Chromosome
1990 StandoutScienceNobel
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Variable Philadelphia breakpoints and potential lineage restriction of bcr rearrangement in acute lymphoblastic leukemia
1988
Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation.
1992 Standout
Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin
1989
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease
1995
Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.
1988 Standout
Congenital and inherited polycythemia
2000
High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
2000 Standout
Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.
1984
A Comprehensive Survey of Ras Mutations in Cancer
2012 Standout
Polycythemia vera: myths, mechanisms, and management
2002
Production of high-titer helper-free retroviruses by transient transfection.
1993 StandoutNobel
Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia.
2005
Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes
1994 StandoutNobel
A Large Proportion of Patients With a Diagnosis of Essential Thrombocythemia Do Not Have a Clonal Disorder and May Be at Lower Risk of Thrombotic Complications
1999
Clonality Analysis of Hematopoiesis in Essential Thrombocythemia: Advantages of Studying T Lymphocytes and Platelets
1997
Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction.
1991
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
ras oncogenes in human cancer: a review.
1989 Standout
Effects of DNA methylation on topoisomerase I and II cleavage activities.
1994 StandoutNobel
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
2008
N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome
1993
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Analysis of c-Ki-ras mutations in human colon carcinoma by cell sorting, polymerase chain reaction, and DNA sequencing.
1989
Giant cell carcinomas of the lung producing colony-stimulating factor in vitro and in vivo.
1985
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.
1989
Works of B. Anger being referenced
Wer hat größere Furcht vor einer Verkürzung der Lebensspanne: palliativ oder kurativ behandelte Krebspatienten?
2009
Polycythemia vera. A clinical study of 141 patients
1989
Daunomycin, cytosin-arabinoside and VP-16 (DAV) for myeloid blast crisis of CML
1989
A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia
1989
Mouse Monoclonal IgM Antibody Against Human Lung Cancer Line SK-LC-3 with Specificity for H(O) Blood Group Antigen
1982
T lymphocytes lack rearrangement of the bcr gene in Philadelphia chromosome-positive chronic myelocytic leukemia
1987
Evidence for pluripotent stem cell origin of idiopathic myelofibrosis: clonal analysis of a case characterized by a N-ras gene mutation.
1988
RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.
1987
Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia
1988
Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms.
1990
Characterization of two newly established human cell lines from patients with large-cell anaplastic lung carcinoma
1982
Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia
1988